Abstract:BACKGROUND: To explore clinical heterogeneity of Duchenne muscular dystrophy (DMD), viewed as a major obstacle to the interpretation of therapeutic trialsMETHODOLOGY/PRINCIPAL FINDINGS: A retrospective single institution long-term follow-up study was carried out in DMD patients with both complete lack of muscle dystrophin and genotyping. An exploratory series (series 1) was used to assess phenotypic heterogeneity and to identify early criteria predicting future outcome; it included 75 consecutive steroid-free patients, longitudinally evaluated for motor, respiratory, cardiac and cognitive functions (median follow-up: 10.5 yrs). A validation series (series 2) was used to test robustness of the selected predictive criteria; it included 34 more routinely evaluated patients (age>12 yrs). Multivariate analysis of series 1 classified 70/75 patients into 4 clusters with distinctive intellectual and motor outcomes: A (early infantile DMD, 20%): severe intellectual and motor outcomes; B (classical DMD, 28%): intermediate intellectual and poor motor outcome; C (moderate pure motor DMD, 22%): normal intelligence and delayed motor impairment; and D (severe pure motor DMD, 30%): normal intelligence and poor motor outcome. Group A patients had the most severe respiratory and cardiac involvement. Frequency of mutations upstream to exon 30 increased from group A to D, but genotype/phenotype correlations were restricted to cognition (IQ>71: OR 7.7, 95%CI 1.6-20.4, p<0.003). Diagnostic accuracy tests showed that combination of "clinical onset <2 yrs" with "mental retardation" reliably assigned patients to group A (sensitivity 0.93, specificity 0.98). Combination of "lower limb MMT score>6 at 8 yrs" with "normal or borderline mental status" reliably assigned patients to group C (sensitivity: 1, specificity: 0.94). These criteria were also predictive of "early infantile DMD" and "moderate pure motor DMD" in series 2.CONCLUSIONS/SIGNIFICANCE: DMD can be divided into 4 sub-phenotypes differing by severity of muscle and brain dysfunction. Simple early criteria can be used to include patients with similar outcomes in future therapeutic trials.

Cognitive and emotional-behavioural outcomes of Turkish Duchenne muscular dystrophy population and its association with motor function

Difficulties in social cognitive functioning among pediatric patients with muscular dystrophies

Pulmonary and upper limbs function in children with early stage Duchenne muscular dystrophy compared to their healthy peers

Early motor, cognitive, language, behavioural and social emotional development in infants and young boys with Duchenne Muscular Dystrophy- A systematic review

Clinical study on cognitive impairment in Duchenne muscular dystrophy

Evolution of neuropsychological and behavioral profile in a cohort of Becker muscular dystrophy pediatric patients in a longitudinal study

Clinical Features in Boys with Duchenne/Becker Muscular Dystrophy: A Tertiary Center Experience

Comparison of hand dexterity and hand laterality task in duchenne muscular dystrophy patients with typically developing peers

Maintaining Physical Health in Individuals with Duchenne Muscular Dystrophy Through Telerehabilitation

Neurocognitive functioning among children and young people with Duchenne Muscular Dystrophy: A systematic review and meta-analysis

Investigation of genotype-phenotype and familial features of Turkish dystrophinopathy patients

The effect of trunk training on trunk control, upper extremity, and pulmonary function in children with Duchenne muscular dystrophy: A randomized clinical trial

Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy

Brain Alteration Patterns in Children with Duchenne Muscular Dystrophy: A Machine Learning Approach to Magnetic Resonance Imaging

The relationship between lower urinary system symptoms and the level of independence and quality of life in children with Duchenne muscular dystrophy

Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study

327P Correlation of biomarkers and timed function tests in pediatric Becker muscular dystrophy

Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study

Social and emotional alterations in mice lacking the short dystrophin-gene product, Dp71

Clinical Heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of Sub-Phenotypes and Predictive Criteria by Long-Term Follow-Up

Computerized working memory training in males with Duchenne muscular dystrophy: A single case experimental design study